DE3875752T2 - Verfahren zur herstellung von aktivierten toetenden zellen. - Google Patents

Verfahren zur herstellung von aktivierten toetenden zellen.

Info

Publication number
DE3875752T2
DE3875752T2 DE8888101138T DE3875752T DE3875752T2 DE 3875752 T2 DE3875752 T2 DE 3875752T2 DE 8888101138 T DE8888101138 T DE 8888101138T DE 3875752 T DE3875752 T DE 3875752T DE 3875752 T2 DE3875752 T2 DE 3875752T2
Authority
DE
Germany
Prior art keywords
producing activated
killing cells
activated killing
specified
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888101138T
Other languages
English (en)
Other versions
DE3875752D1 (de
Inventor
Joseph David Irr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of DE3875752D1 publication Critical patent/DE3875752D1/de
Application granted granted Critical
Publication of DE3875752T2 publication Critical patent/DE3875752T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mushroom Cultivation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8888101138T 1987-01-29 1988-01-27 Verfahren zur herstellung von aktivierten toetenden zellen. Expired - Fee Related DE3875752T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US827387A 1987-01-29 1987-01-29

Publications (2)

Publication Number Publication Date
DE3875752D1 DE3875752D1 (de) 1992-12-17
DE3875752T2 true DE3875752T2 (de) 1993-04-22

Family

ID=21730714

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888101138T Expired - Fee Related DE3875752T2 (de) 1987-01-29 1988-01-27 Verfahren zur herstellung von aktivierten toetenden zellen.

Country Status (13)

Country Link
EP (1) EP0280054B1 (de)
JP (1) JPH06104060B2 (de)
KR (1) KR900004421B1 (de)
AT (1) ATE82319T1 (de)
AU (1) AU609768B2 (de)
CA (1) CA1300058C (de)
DE (1) DE3875752T2 (de)
DK (1) DK42188A (de)
ES (1) ES2052611T3 (de)
IE (1) IE880224L (de)
IL (1) IL85238A (de)
NZ (1) NZ223326A (de)
ZA (1) ZA88656B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2543719A1 (de) 2011-07-08 2013-01-09 Zellwerk GmbH Mäander-Bioreaktor und Verfahren zur dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826298D0 (en) * 1988-11-10 1988-12-14 Williams N S Production of lak cells compositions containing them & their use in cancer therapy
DE69012105T2 (de) * 1989-02-21 1994-12-22 Terumo Corp Proliferation von cd4-lymfocyten.
CA2015294A1 (en) * 1989-04-28 1990-10-28 John J. Rinehart Generation and expansion of lak cells
US6190913B1 (en) * 1997-08-12 2001-02-20 Vijay Singh Method for culturing cells using wave-induced agitation
US7745209B2 (en) 2005-07-26 2010-06-29 Corning Incorporated Multilayered cell culture apparatus
CA2671967A1 (en) 2006-12-07 2008-06-19 Wilson Wolf Manufacturing Corporation Highly efficient devices and methods for culturing cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140162A (en) * 1977-07-28 1979-02-20 Baxter Travenol Lab Clear, autoclavable plastic formulation free of liquid plasticizers
US4280497A (en) * 1979-10-09 1981-07-28 Cutter Laboratories, Inc. Container for platelet storage
GB2065067B (en) * 1979-10-15 1983-06-22 Toppan Printing Co Ltd Laminated bags
US4496361A (en) * 1981-08-05 1985-01-29 E. I. Du Pont De Nemours And Company Platelet storage container
JPS5829465A (ja) * 1981-08-05 1983-02-21 イ−・アイ・デユ・ポン・ドウ・ヌム−ル・アンド・カンパニ− 血小板貯蔵容器
US4588401A (en) * 1982-06-29 1986-05-13 E. I. Du Pont De Nemours And Company Platelet storage container
JPS60160881A (ja) * 1984-01-03 1985-08-22 イ−・アイ・デユポン・ド・ネモア−ス・アンド・コンパニ− 細胞培養室のための薄いフイルム

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2543719A1 (de) 2011-07-08 2013-01-09 Zellwerk GmbH Mäander-Bioreaktor und Verfahren zur dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
DE102011106914A1 (de) 2011-07-08 2013-01-10 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
DE102011106914B4 (de) * 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen

Also Published As

Publication number Publication date
JPS63202378A (ja) 1988-08-22
DK42188D0 (da) 1988-01-28
ZA88656B (en) 1989-09-27
NZ223326A (en) 1989-10-27
EP0280054B1 (de) 1992-11-11
CA1300058C (en) 1992-05-05
KR880009123A (ko) 1988-09-14
ATE82319T1 (de) 1992-11-15
ES2052611T3 (es) 1994-07-16
DE3875752D1 (de) 1992-12-17
EP0280054A1 (de) 1988-08-31
AU1076188A (en) 1988-08-04
JPH06104060B2 (ja) 1994-12-21
DK42188A (da) 1988-07-30
KR900004421B1 (ko) 1990-06-25
IL85238A (en) 1992-03-29
IE880224L (en) 1988-07-29
IL85238A0 (en) 1988-07-31
AU609768B2 (en) 1991-05-09

Similar Documents

Publication Publication Date Title
DE69019182D1 (de) Verfahren zur Herstellung von transparentem keramischem Material hoher Dichte.
DE3885637T2 (de) Verfahren zur Herstellung von gleichmässigen Materialschichten.
DE3854125T2 (de) VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON FAKTOR VIII:c-TYP-PROTEINEN.
DE59007717D1 (de) Verfahren zur Herstellung von mit keramischen Pulvern gefüllten thermoplastischen Kunststoffen.
DE3889275D1 (de) Sol-Gel-Verfahren zur Herstellung von dünnen lumineszierenden Filmen.
AT383606B (de) Verfahren zur herstellung von neuen transparenten copolyamiden mischungen daraus, und deren verwendung zur herstellung von formkoerpern
DE3875752T2 (de) Verfahren zur herstellung von aktivierten toetenden zellen.
DE3851462D1 (de) Verfahren zur Herstellung eines supraleitenden Materials des Oxydverbundtyps.
DE69025100T2 (de) Verfahren zur Herstellung von Polycarbonaten mit kontrolliertem Molekulargewicht aus Bischloroformiaten
DE69430975T2 (de) Verfahren zur Herstellung von Proteinen
DE3888094T2 (de) Verfahren zur Herstellung von geformten porösen Artikeln.
DE68923356T2 (de) Verfahren zur Herstellung von Graphitwhiskern.
DE69130237T2 (de) Verfahren zur Herstellung von Kompositmaterial
DE59004588D1 (de) Verfahren zur Herstellung von Purpurmembran enthaltend Bacteriorhodopsin.
DE68912298D1 (de) Verfahren zur herstellung von stabilen dispersionen eines teilchenförmigen materials.
DE69107005T2 (de) Verfahren zur Herstellung von Formstoff und Formstoff.
DE69116240T2 (de) Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung
ATE60802T1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
DE69018539D1 (de) Verfahren zur Herstellung von supraleitenden Dünnschichten.
DE3785928T2 (de) Verfahren zur Herstellung einer ausgebreiteten Struktur mit Leder als Hauptteil und so hergestellte Struktur.
AT372374B (de) Verfahren zur herstellung der neuen lactate von 1-glaucin, d,1-glaucin und deren gemischen
ATE86976T1 (de) 3-(2-hydroperoxy-2-propyl)phenol und verfahren zur herstellung von resorcin mit diesem phenol.
ATA96778A (de) Verfahren zur herstellung von neuen 3-(2',2', 2',1'-tetrahalogenaethyl)-cyclopropancarbon- saeuren und deren hallogeniden
DE3767718D1 (de) Verfahren zur herstellung von komposit-lagermaterial und so erzeugtes lager.
ATA338479A (de) Verfahren zur herstellung von neuen 1,3-dihydrosprio(isobenzofuran-1,4'-piperidinen) und von deren salzen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee